Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia

Somatic mutation of the DNMT3A gene at the arginine R882 site is common in acute myeloid leukaemia (AML). The prognostic significance of DNMT3A R882 mutation clearance, using traditional diagnostic next generation sequencing (NGS) methods, during complete remission (CR) in AML patients is controvers...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Haematol
Главные авторы: Bhatnagar, Bhavana, Eisfeld, Ann-Kathrin, Nicolet, Deedra, Mrózek, Krzysztof, Blachly, James S., Orwick, Shelley, Lucas, David M., Kohlschmidt, Jessica, Blum, William, Kolitz, Jonathan E., Stone, Richard M., Bloomfield, Clara D., Byrd, John C.
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063708/
https://ncbi.nlm.nih.gov/pubmed/27476855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14254
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы